Business
Grant of Share Options
Grant of Share Options.
About this update from Ixico Plc
[{"type":"text","content":"\n \n \n \n 14 September 2022\n \n \n \n \n \n \n IXICO plc\n \n \n (\"IXICO\" or the \"Company\")\n \n \n \n \n \n \n \n Grant of Share Options\n \n \n \n \n \n IXICO plc (AIM: IXI),\n the medical imaging advanced analytics company delivering intelligent insights in neuroscience\n , today\n announces that it has granted 600,000 options over the ordinary shares in the Company in accordance with the rules of the Company's EMI Share Option Plan 2014 (the 'Plan'). These options have been awarded across twenty-four employees within the Company and will be exercisable at a price of 29.3p (being at a 25% discount to the closing middle market price per ordinary share on 13 September 2022).\n \n \n \n \n \n The options are subject to performance conditions linked to revenues and retention within the Company across three years. No PDMR has received options under this award.\n \n \n \n \n \n The Company's Remuneration Committee has also reviewed the performance conditions of the December 2019 and July 2020 LTIPs and, acting within the share option scheme rules, amended the review of performance conditions to be annually on the anniversary of each LTIP award. The vesting condition of 50% of the respective award vesting on the third anniversary of the award, with the remaining 50% of the respective award vesting on the fourth anniversary of the award will remain.\n \n \n \n \n \n \n \n \n For further information please contact:\n \n \n \n \n \n \n \n \n \n \n \n \n \n IXICO plc\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Giulio Cerroni, Chief Executive Officer\n \n \n Grant Nash, Chief Financial Officer\n \n \n \n \n +44 (0)20\n 3763 7499\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Cenkos Securities PLC (Nominated adviser and sole broker)\n \n \n \n \n \n +44 (0)20 7397 8900\n \n \n \n \n \n \n Giles Balleny / Max Gould (Corporate Finance)\n \n \n \n \n \n \n \n \n \n \n \n \n \n Michael F Johnson /\n Tamar Cranford-Smith\n (Sales)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n About IXICO | Advanced Analytics | Intelligent Insights.\n \n \n IXICO is dedicated to delivering insights in neuroscience to help transform the advancement of investigational therapies for n...